Spyre Therapeutics, Inc. (SYRE) Prices $350M Equity Offering at $85
Spyre Therapeutics priced 4,117,648 common shares at $85 for expected gross proceeds of ~$350M, with a 30-day option for up to ~$52.5M more. Closing is expected on or about Oct. 7, 2026, subject to customary conditions.Material DetailsContext by AI AnalystThis is a follow-on raise to fund an expand…